We are a biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. We have developed a proprietary technology that enables us to develop and manufacture active immunotherapy products that are designed to stimulate a patient's immune system to mount a specific and sustained response to disease. Our lead product candidate, Specifid™ (former...More >>
Receive E-mail Alerts | | Sign up to receive e-mail alerts whenever Favrille Inc. posts new information to the site. Just enter your e-mail address and click Submit. |
| | |
